Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Picks of the quarter -- Ignore unavailable to you. Want to Upgrade?

To: Elroy who wrote (18465)	12/18/2015 7:50:21 AM
From: freelyhovering	Read Replies (1) \| Respond to of 20435

I own 25 shares of KBIO and my broker, Ameritrade, docked me with a price of 11.89. I think Bonefish should get that price since that is the REAL WORLD at this stage of the game. Anything else would be unfair to him. I am in reality down $292+.for 25 shares.

To: Elroy who wrote (18465)	12/18/2015 9:25:42 AM
From: Peace	Read Replies (2) \| Respond to of 20435

I agree with the judges. Pre and post market prices are never a true indicator as there is less access and liquidity. Daily regular session closing prices are always used to settle everything. Lets make it clear going forward that only regular session prices will be used for the contest. But lets hope that the stock trades today so we get a fair price.

To: Elroy who wrote (18465)	12/18/2015 10:22:27 AM
From: Kirk ©	Read Replies (1) \| Respond to of 20435

It is unfortunate, but it is good we all seem to agree. Well, all three judges have opined, and as far as I can tell all say the price for the stock if it doesn't open is Wednesday's close. So ..... you better hope it opens for trading today! Hopefully they get it open as it was a good pick to short but if they don't then it is little different than a long getting bought out for a huge premium with stock announced after hours on the last day of the contest.

To: Elroy who wrote (18465)	12/18/2015 12:42:58 PM
From: Bonefish	Respond to of 20435

Fat chance of it opening now. The Lawyers have moved in. KaloBios Pharmaceuticals, Inc. - Information Request FormLevi & Korsinsky, LLP announces that it has commenced an investigation of KaloBios Pharmaceuticals, Inc. ("KaloBios" or the "Company") (NASDAQGM: KBIO) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On December 17, 2015, news outlets reported that Martin Shkreli, the CEO of KaloBios, was arrested on securities fraud charges relating to his illegal use of stock from Retrophin Inc. to pay off debts associated with other unrelated business ventures. On this news, KaloBios shares plummeted pre-market, and trading has since been halted. To receive more information regarding the investigation of KaloBios please fill out the form below. zlkdocs.com marketwatch.com My best guess is it's worth closer to ZERO.